What Is The Predicted Revenue Outlook For The Global Pediatric Asthma Treatment Market To Surpass $14.39 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
#What Are The Market Size Estimates For The Pediatric Asthma Treatment Market?#_x000D_
The market for pediatric asthma treatment has seen robust growth in recent periods. The market size will increase from $11.03 billion in 2024 to reach $11.65 billion in 2025, with a compound annual growth rate (CAGR) of 5.6%. The historic expansion can be linked to factors like growing incidents of asthma among children, increased understanding about children’s respiratory issues, a rise in environmental allergens and air pollution, amplified health care spending on child care, and the campaigns run by NGOs and healthcare bodies for asthma awareness._x000D_
_x000D_
The market size for treatment of pediatric asthma is anticipated to experience robust growth in the upcoming years, with an expected growth to $14.39 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. Factors that attribute to this growth within the forecast period include an increase in allergic disorders among children, enlargement of biologic therapies for severe cases of pediatric asthma, rise in investments targeted towards pediatric drug development, a higher focus on personalized and precision medicine, and a growing middle class with access to private healthcare. Noteworthy trends within the forecast period are the development of biologic therapies that are pediatric-friendly, creation of rapid tools for the identification of allergens, incorporation of electronic health records, advances in inhaler formulations, and breakthroughs in immunotherapy treatments for asthma._x000D_
_x000D_
#Get A Free Sample Of The Report:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=25868&type=smp_x000D_
_x000D_
#Which Industry Forces Are Driving The Pediatric Asthma Treatment Market Forward?#_x000D_
The growth of the pediatric asthma treatment market is anticipated to be spurred by the escalating occurrence of respiratory diseases. These diseases, which mainly affect the respiratory tract including the nose, throat, airways, and lungs, are attributed to the exponentially increasing air pollution. Harmful pollutants such as particulate matter and nitrogen dioxide detrimentally impact the respiratory system, making it more prone to infections. Moreover, pediatric asthma treatment plays a crucial role in decreasing the frequency and severity of these infections by enhancing airway productivity and reducing inflammation, thereby intensifying protection against infectious activities. For instance, the Australian Institute of Health and Welfare reported in June 2024 that in 2023, chronic obstructive pulmonary disease constituted 3.6% of the total disease burden and made up 50% of the total respiratory conditions burden. In 2022, it was estimated that 638,000 individuals representing 2.5% of the Australian population were diagnosed with chronic obstructive pulmonary disease. As a result, the surging incidences of respiratory infections significantly contribute to the expansion of the pediatric asthma treatment market._x000D_
_x000D_
#How Is The Pediatric Asthma Treatment Market Organized By Different Segments?#_x000D_
The pediatric asthma treatment market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Long-Term Control Medications, Quick-Relief Medications, Other Types_x000D_
2) By Drug Class: Inhaled Corticosteroids, Long-Acting Beta Agonists, Leukotriene Modifiers, Antihistamines, Biologics_x000D_
3) By Route Of Administration: Oral Route, Nasal Route, Injectable Route_x000D_
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_
5) By End User: Hospitals, Clinics, Home Care, Other End users_x000D_
_x000D_
Subsegments:_x000D_
1) By Long-Term Control Medications: Inhaled Corticosteroids, Leukotriene Modifiers, Long-Acting Beta Agonists, Combination Inhalers, Biologic Therapies_x000D_
2) By Quick-Relief Medications: Short-Acting Beta Agonists, Anticholinergics, Systemic Corticosteroids_x000D_
3) By Other Types: Immunotherapy, Methylxanthines, Alternative Therapies_x000D_
_x000D_
#What Current And Upcoming Trends Are Shaping The Pediatric Asthma Treatment Market?#_x000D_
Leading firms in the pediatric asthma treatment market are concentrating their efforts on the creation of novel therapies like monoclonal antibodies to minimize airway inflammation in kids. These laboratory-made proteins act like the immune system’s defense against harmful pathogens by specifically targeting certain cells or elements. To illustrate, AstraZeneca PLC, a pharmaceutical and biotechnology company based in the UK, was granted authorization in April 2024 by the U.S. Food and Drug Administration for FASENRA (benralizumab) as an additional continuing treatment for children between 6 to 11 years suffering from severe asthma marked by an eosinophilic phenotype. This antibody is designed to decrease asthma attacks and enhance symptom control by targeting and eradicating eosinophils. Fasenra is given via subcutaneous injection initially every 4 weeks for the first three doses and then every 8 weeks, with pediatric dosing being adjusted according to body weight._x000D_
_x000D_
#Who Are The Primary Market Leaders In The Pediatric Asthma Treatment Market?#_x000D_
Major companies operating in the pediatric asthma treatment market are Pfizer Inc., Merck And Co Inc., Novartis AG, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Genentech Inc., Chiesi Farmaceutici S.p.A, Dr. Reddy’s Laboratories Ltd, Cipla Ltd, Lupin Limited, Zydus Lifesciences Ltd., ECU Health. _x000D_
_x000D_
#Access The Complete Report Here:#_x000D_
_x000D_
#How Do Regional Dynamics Influence The Pediatric Asthma Treatment Market Performance?#_x000D_
North America was the largest region in the pediatric asthma treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric asthma treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Customize Your Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=25868&type=smp_x000D_
_x000D_
Browse Through More Reports Similar to the Global Pediatric Asthma Treatment Market 2025, By The Business Research Company_x000D_
_x000D_
Pediatric Clinical Trials Global Market Report 2025_x000D_
_x000D_
Bronchitis Treatment Global Market Report 2025_x000D_
https://www.thebusinessresearchcompany.com/report/bronchitis-treatment-global-market-report_x000D_
_x000D_
Allergy Treatment Global Market Report 2025_x000D_
https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
